STAT3 and prostate carcinoma: Expression of ANO5 is downregulated in thyroid cancer, and knockdown of ANO5 promotes cell migration and invasion via regulation of the JAK/STAT3 signaling pathway.25 However, the exact role of ANO5 in prostate cancer has yet to be determined.